共 11 条
- [1] Effects of the adenosine A1 receptor antagonist, KW-3902, alone and in combination with furosemide, on diuresis and renal function in hospitalized acutely decompensated heart failure patients with renal impairment:: A randomized, double-blind, placebo-controlled, dose-ranging studyJOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S70 - S70Dittrich, Howard C.Tansey, MichaelCotter, GadiFields, Tara K.Pearson, Leeanne L.Massie, Barry M.
- [2] Effect of the adenosine A1 receptor antagonist, KW-3902, on diuresis and renal function in patients with acute decompensated heart failure refractory to maximum doses of conventional diuretics:: A randomized, double-blind, placebo controlled, dose escalation studyCIRCULATION, 2006, 114 (18) : 440 - 440Givertz, Michael M.Tansey, MichaelPearson, Leeanne L.Fields, Tara K.Dittrich, Howard C.
- [3] Effect of the adenosine A1 receptor antagonist, KW-3902, on diuresis and renal function in patients with acute decompensated heart failure refractury to maximum doses of conventional diuretics:: A randomized, double-blind, placebo controlled, dose escalation studyJOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S82 - S83Givertz, Michael M.Tansey, MichaelPearson, Leeanne L.Fields, Tara K.Dittrich, Howard C.
- [4] The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistanceJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (16) : 1551 - 1560Givertz, Michael M.Massie, Barry M.Fields, Tara K.Pearson, Leeanne L.Dittrich, Howard C.
- [5] The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in subjects with heart failure and renal impairment:: A randomized, double-blind, placebo-controlled, two-way crossover studyJOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S82 - S82Dittrich, Howard C.Gupta, Dinesh K.Hack, Terrence E.Dowling, ThomasTansey, MichaelCallahan, JanThomson, Scott C.
- [6] The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in subjects with heart failure and renal impairment:: A randomized, double-blind, placebo-controlled, two-way crossover studyCIRCULATION, 2006, 114 (18) : 570 - 570Dittrich, Howard C.Gupta, DineshDowling, ThomasHack, TerrenceTansey, MichaelCallahan, Janice D.Thompson, Scott
- [7] Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (19) : 1899 - 1907Voors, Adriaan A.Dittrich, Howard C.Massie, Barry M.DeLucca, PaulMansoor, George A.Metra, MarcoCotter, GadWeatherley, Beth D.Ponikowski, PiotrTeerlink, John R.Cleland, John G. F.O'Connor, Christopher M.Givertz, Michael M.
- [8] The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal ImpairmentJOURNAL OF CARDIAC FAILURE, 2008, 14 (08) : 631 - 640Cotter, GadDittrich, Howard C.Weatherley, Beth DavisonBloomfield, Daniel M.O'Connor, Christopher M.Metra, MarcoMassie, Barry M.
- [9] Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal FunctionJOURNAL OF CARDIAC FAILURE, 2010, 16 (01) : 25 - 35Weatherley, Beth DavisonCotter, GadDittrich, Howard C.Delucca, PaulMansoor, George A.Bloomfield, Daniel M.Ponikowski, PiotrO'Connor, Christopher M.Metra, MarcoMassie, Barry M.
- [10] Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure:: A double-blind, placebo-controlled, ascending-dose trial -: art. no. 1239.e1-1239.e8AMERICAN HEART JOURNAL, 2005, 150 (06) : 1239.e1 - 1239.e8Mitrovic, VLüss, HNitsche, KForssmann, KMaronde, EFricke, KForssmann, WGMeyer, M